Anthropic Says It Will Revolutionize Biology—Some Day
Source: Wired ·
In breathless press releases and posts, the company has touted its models’ ability to deliver scientific breakthroughs. But its IPO filing taps the brakes on just how fast its AI will lead to big discoveries.
From the source
AI giant Anthropic and CEO Dario Amodei have repeatedly claimed that the company’s models will revolutionize biology and drug discovery . But in its IPO filing Monday , Anthropic struck a humbler note, acknowledging its lack of experience in physical experimentation and the potential pitfalls of drug development. Wherever it’s going, it seems, it will take some time to get there. Two years ago, Amodei wrote that he was “open” to the idea that AI systems could produce a thousand years of progress in biology in just five to 10 years. In August, he said on X that “Anthropic is ramping up its efforts very quickly in biology and medicine.” In the same post, he predicted that AI will make it possible to cure most human diseases in the next five to 10 years and promised a “deluge of AI-accelerated drugs.” The company also promoted the discovery of a “Crispr-like” enzyme by Claude in September. While the new IPO filing still touts AI’s ability to “profoundly accelerate the rate of progress…